Celldex (CLDX)
28.97
-0.40 (1.36%)
Upcoming Events
Latest Headlines
Form SCHEDULE 13G/A Celldex Therapeutics, Filed by: FMR LLC
October 7, 2026 11:47 AM - SEC Filing
Guggenheim says investors should own this biotech stock
September 27, 2026 4:00 AM - StreetInsider
Celldex Therapeutics (CLDX) PT Raised to $57 at Morgan Stanley
September 23, 2026 6:19 AM - StreetInsider
Stifel Reiterates Buy Rating on Celldex Therapeutics (CLDX)
September 22, 2026 10:21 AM - StreetInsider
Form 8-K Celldex Therapeutics, For: Sep 22
September 22, 2026 7:09 AM - SEC Filing
Celldex's barzolvolimab meets Phase 3 endpoints in chronic hives trial
September 22, 2026 6:58 AM - StreetInsider
Celldex Announces Positive Results from Phase 3 EMBARQ-CSU1 and EMBARQ-CSU2 Studies of Barzolvolimab Which Met Primary and All Key Secondary Endpoints
September 22, 2026 6:58 AM - Globe NewsWire
Celldex Therapeutics (CLDX) PT Raised to $50 at Morgan Stanley
September 10, 2026 7:59 AM - StreetInsider
Celldex to Present at Upcoming Investor Conference
September 8, 2026 4:01 PM - Globe NewsWire
Form SCHEDULE 13G/A Celldex Therapeutics, Filed by: Kynam Capital Management, LP
August 14, 2026 12:09 PM - SEC Filing
Form SCHEDULE 13G Celldex Therapeutics, Filed by: PRICE T ROWE ASSOCIATES INC /MD/
August 14, 2026 10:39 AM - SEC Filing
Celldex Therapeutics (CLDX) PT Raised to $53 at Barclays
August 7, 2026 4:53 AM - StreetInsider
Form 10-Q Celldex Therapeutics, For: Jun 30
August 6, 2026 4:08 PM - SEC Filing
Celldex (CLDX) Tops Q2 EPS by 12c
August 6, 2026 4:05 PM - StreetInsider
Form 8-K Celldex Therapeutics, For: Aug 06
August 6, 2026 4:02 PM - SEC Filing
Celldex Reports Second Quarter Financial Results and Provides Corporate Update
August 6, 2026 4:01 PM - Globe NewsWire
Celldex Therapeutics (CLDX) PT Raised to $72 at Wells Fargo
July 29, 2026 8:13 AM - StreetInsider
Full Article List
